首页> 外国专利> A METHOD FOR THE TREATMENT, PREVENTION, OR INHIBITION OF A CNS DISORDER AND/OR PAIN AND INFLAMMATION USING A COMBINATION OF DULOXETINE, VENLAFAXINE OR ATOMOXETINE AND A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND COMPOSITIONS THEREOF

A METHOD FOR THE TREATMENT, PREVENTION, OR INHIBITION OF A CNS DISORDER AND/OR PAIN AND INFLAMMATION USING A COMBINATION OF DULOXETINE, VENLAFAXINE OR ATOMOXETINE AND A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND COMPOSITIONS THEREOF

机译:结合度洛西汀,文拉法辛或阿托莫西​​汀和环氧化酶-2选择性抑制剂的治疗,预防或抑制中枢神经系统疾病和/或疼痛和发炎的方法及其成分

摘要

A method of treating, preventing, or inhibiting a CNS disorder and/or pain andinflammation or an inflammation-associated disorder in a subject in need ofsuch treatment or prevention provides for treating the subject withduloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selectiveinhibitor or prodrug thereof, wherein the amount of duloxetine, venlafaxine oratomoxetine and the amount of a cyclooxygenase-2 selective inhibitor orprodrug thereof together constitute a CNS disorder, pain and inflammation, orinflammation-associated disorder suppressing treatment, prevention, orinhibition effective amount of the composition. Compositions andpharmaceutical compositions that contain duloxetine, venlafaxine oratomoxetine and a cyclooxygenase-2 selective inhibitor are also disclosed.
机译:一种治疗,预防或抑制中枢神经系统疾病和/或疼痛的方法和需要治疗的受试者中的炎症或与炎症相关的疾病这种治疗或预​​防提供了用度洛西汀,文拉法辛或托莫西汀和环氧合酶-2选择性抑制剂或其前药,其中度洛西汀,文拉法辛或阿托西汀和环氧合酶2选择性抑制剂的量或其前药共同构成中枢神经系统疾病,疼痛和炎症,或炎症相关疾病的抑制,治疗或预防抑制有效量的组合物。成分和含有度洛西汀,文拉法辛或还公开了阿托西汀和环氧合酶-2选择性抑制剂。

著录项

  • 公开/公告号CA2508884A1

    专利类型

  • 公开/公告日2004-07-22

    原文格式PDF

  • 申请/专利权人 PHARMACIA CORPORATION;

    申请/专利号CA20032508884

  • 发明设计人 ARNERIC STEPHEN P.;

    申请日2003-12-06

  • 分类号A61K31/38;A61K31/415;

  • 国家 CA

  • 入库时间 2022-08-21 23:04:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号